Introduction Varicose veins are a common cause of deterioration in quality of life. Chronic venous disease (CVD) is highly prevalent yet underdiagnosed. This discrepancy in care may change with better insights into the pathophysiological development of CVD. Objective In this retrospective study, we aimed to assess the ability of the neutrophil-lymphocyte ratio (NLR), a single inflammatory marker, in screening for primary varicose veins. Methods A total of 130 patients aged 21-70 years diagnosed with primary varicose veins from January 1, 2016, to January 30, 2023, were retrospectively studied at the Department of General Surgery, Kasturba Medical College, Manipal. Patients were divided into two groups based on their degree of primary varicose veins using the Clinical-Etiology-Anatomy-Pathophysiology (CEAP) classification. Group 1 included patients with varicose veins with CEAP stage ≤ C3 and group 2 included patients with varicose veins with CEAP stage > C3. Complete blood counts taken at diagnosis were used for NLR calculation. Results Absolute neutrophil counts (CI 95%), absolute lymphocyte counts (CI 99%), and NLRs were all statistically significant inflammatory markers in both groups. NLR was found to have a strong statistically significant association with the diagnosis of primary varicose veins (p-value<0.001). NLRs were lower in group 1 than in group 2. Conclusion This study conclusively finds that NLR may effectively be considered to track the incidence of primary varicose veins in patients after further studies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11569789 | PMC |
http://dx.doi.org/10.7759/cureus.71776 | DOI Listing |
Phlebology
January 2025
Division of Vascular Surgery - 2nd Department of Surgery, "G. Gennimatas" Hospital, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Objective: To perform a systematic review and meta-analysis to investigate the efficacy of ultrasonography in the diagnosis of pelvic vein insufficiency (PVI).
Results: Seven studies comprised of 802 patients were included. Of these studies, 5 utilised transvaginal ultrasound (TVU), 1 utilised transabdominal ultrasound (TAU) and 1 utilised both ultrasounds as diagnostic tool .
Phlebology
January 2025
Research Department, Valley Vein Health Center, Turlock, CA, USA.
Purpose: Determine the rate of incidence, risk factors, and management for developing venous thromboembolism (VTE) in patients undergoing radiofrequency ablation (RFA) and ultrasound-guided foam sclerotherapy (UGFS) for varicose veins.
Methods: All charts of patients undergoing venous ablation from 2016 to 2023 were reviewed at a rural vein treatment clinic. The incidence of VTE was noted and a chart review was completed to identify risk factors for VTE, EHIT score, EFIT score, and management.
BMC Health Serv Res
January 2025
Valley Vein Health Center, 840 Delbon Ave, Turlock, CA, 95382, USA.
Objective: To evaluate patient preferences when utilizing telemedicine.
Methods: A 5-point Likert scale questionnaire was completed by 153 patients at a rural clinic via a convenience sampling method. The survey contained 21 statements encompassing provider confidence, patient-physician rapport, and accessibility variables.
Med J Armed Forces India
December 2024
Senior Medical Officer (Dermatology), Govt of NCT of Delhi, Bhagwan Mahavir Hospital, Pitampura, Delhi, India.
Background: Chronic venous insufficiency (CVI) causes cutaneous changes. This prospective observational study reveals dermoscopic findings in CVI.
Methods: Successive CVI patients of ≥18 years were included in the study.
J Vasc Surg Venous Lymphat Disord
December 2024
Beijing Shijitan Hospital, No.10 Tieyi Road, Haidian District, Beijing, China, 100038. Electronic address:
Objective: The study aims to elucidate clinical and ultrasonographic characteristics of female patients diagnosed with pelvic varicose veins (PVV) and to assess potential risk factors associated with incidences of chronic pelvic pain (CPP) in this population.
Methods: Clinical and ultrasound data were retrospectively collected from female patients with PVV at Beijing Shijitan Hospital between December 2017 and October 2022. Patient cohorts were divided into two groups based on whether they had been experiencing non-periodic pelvic pain over six months, consistent with the symptoms of CPP.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!